Post by
Noteable on Oct 25, 2022 12:26pm
Slowdown in Covid-19 sales will further move Pfizer to M&A
https://www.fiercepharma.com/pharma/pfizer-set-charge-between-110-and-130-covid-vaccine-when-us-goes-commercial-model
Comment by
Noteable on Oct 25, 2022 12:33pm
This near-term eventuality adds to the rationale for an ONCY acquisition north of US$8 Billion.
Comment by
Buckhenry on Oct 25, 2022 12:53pm
you folks are all over the place on wishing and hoping here. I've heard from 15 to 8 to 4 to 2.9 billion. the pattern here is no one knows squat but keep up the wishing.. its fun to read. blue skies